Enliven Therapeutics, Inc.
ELVN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20 | -$25 | -$29 | -$23 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $8 | $7 | $5 |
| Change in WC | -$0 | $0 | -$2 | -$1 |
| Other Non-Cash | $7 | $0 | $0 | $1 |
| Operating Cash Flow | -$13 | -$17 | -$24 | -$17 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$72 | -$240 | -$59 | -$117 |
| Inv. Sales/Matur. | $68 | $57 | $61 | $117 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$4 | -$184 | $1 | $1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$0 | $218 | $0 | -$51 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $90 |
| Financing Cash Flow | -$0 | $218 | $0 | $40 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$18 | $18 | -$22 | $23 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $119 | $102 | $124 | $101 |
| End Cash | $102 | $119 | $102 | $124 |
| Free Cash Flow | -$13 | -$17 | -$24 | -$17 |